Newsletter

South Korea: Upcoming Amendments to the Medical Device Act and Revisions to the Regulation on the Permission, Notification, Review, Etc. of Medical Devices – May/June 2026

South Korea: Upcoming Amendments to the Medical Device Act and Revisions to the Regulation on the Permission, Notification, Review, Etc. of Medical Devices – May/June 2026

  • 2026-06-26 05:40:00

South Korea has introduced amendments to both the Medical Device Act and the Regulation on Medical Device Approval, Notification, and Review, bringing important updates for manufacturers and importers. Key changes include expanded use of real-world evidence (RWE), simplified documentation requirements, a broader transition period for approved changes, and the establishment of a formal quality management system (QMS) conformity recognition framework. The amendments reflect South Korea's ongoing efforts to enhance regulatory efficiency, strengthen oversight, and support innovation in the medical device sector.

More
Malaysia: Amendment Regulations 2025 [P.U. (A) 330] – Class A Change Payment Fee – October/November 2025

Malaysia: Amendment Regulations 2025 [P.U. (A) 330] – Class A Change Payment Fee – October/November 2025

  • 2025-11-21 08:14:15

The Malaysian Medical Device Authority (MDA) has issued the Medical Device (Amendment) Regulations 2025 [P.U.(A) 330], which were gazetted on 11 September 2025. This amendment revises the fee structure for registrations of Class A medical device effective on or after 1 January 2026. Stakeholders are advised to review the changes and plan their submissions accordingly to ensure timely compliance.

More
SOUTH KOREA: AMENDMENT TO THE MEDICAL DEVICE ENFORCEMENT RULES AND MEDICAL DEVICE STANDARDS - AUGUST/SEPTEMBER 2025

SOUTH KOREA: AMENDMENT TO THE MEDICAL DEVICE ENFORCEMENT RULES AND MEDICAL DEVICE STANDARDS - AUGUST/SEPTEMBER 2025

  • 2025-09-24 08:47:47

The Ministry of Food and Drug Safety (MFDS) has announced amendments to both the Enforcement Rules of the Medical Device Act and the Medical Device Standards. The revisions, implemented between April and August 2025, included higher fees for innovative medical device reviews, exemptions from documentation requirements, stricter administrative sanctions, and the establishment of long-term follow-up requirements. In addition, amendments to the Medical Device Standards have been finalized and are scheduled to take effect in July 2026, introducing new standards and aligning existing ones with international norms.

More
Thailand: Updated Change Notification Guidelines for IVD and Non-IVD: Model Additions/Removals and Amendments to Thai Establishment Information on Labels – March/April 2025

Thailand: Updated Change Notification Guidelines for IVD and Non-IVD: Model Additions/Removals and Amendments to Thai Establishment Information on Labels – March/April 2025

  • 2025-03-25 10:37:19

The Thai FDA updated its change notification guidelines, effective 15 January 2025, focusing on model additions/removals and importer/manufacturer info updates for both IVD and non-IVD devices. The update allows modifications to groupings when adding or removing products within the same application. Additionally, adding models is now classified as a Major Change, requiring an extensive documentation.

More
VIETNAM: Amendments on Goods Labeling – February, 2022

VIETNAM: Amendments on Goods Labeling – February, 2022

  • 2022-02-18 09:44:59

On 9 December 2021, the Vietnamese government issued Decree No. 111/2021/ND-CP amending and supplementing a number of articles of Decree No. 43/2017/ND-CP on Goods Labels, including medical devices ("Decree 111"), which will take effect as of 15 February 2022.

More